NAA10 and systemic lupus erythematosus: Given that circulating anti-MAA antibodies have been reported in other rheumatologic conditions such as SLE and OA, albeit at lower concentrations than observed in RA, further research is needed to identify whether anti-MAA antibodies might also contribute to disease progression in rheumatic disease s beyond RA.